Role of contrast-enhanced ultrasound in evaluation of the bowel.
Contrast-enhanced ultrasound (CEUS) of the gastrointestinal tract provides vascular information helpful for characterizing masses and other pathologies in and around the bowel, similar to contrast applications in other solid organs. However, the use of microbubble contrast agents for the bowel provi...
| Publicado en: | Abdominal Radiology Vol. 43; no. 4; pp. 918 - 934 |
|---|---|
| Autores principales: | , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
Apr2018
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=128888768&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 128888768 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 2366004X JT14 jtl: Abdominal Radiology issn: 2366004X maglogo: N pubinfo: dt: Apr2018 vid: 43 iid: 4 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 128888768 10.1007/s00261-017-1399-6 128888768 ppf: 918 ppct: 16 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Role of contrast-enhanced ultrasound in evaluation of the bowel. aug: au: Medellin, Alexandra Merrill, Christina Wilson, Stephanie R. affil: Department of Radiology, University of Calgary, Foothills Medical Centre, 1403 29 St. NW, T2N 2T9, Calgary, AB, Canada sug: ab: Contrast-enhanced ultrasound (CEUS) of the gastrointestinal tract provides vascular information helpful for characterizing masses and other pathologies in and around the bowel, similar to contrast applications in other solid organs. However, the use of microbubble contrast agents for the bowel provides additional unique contributions as it gives both subjective and objective information about mural and mesenteric blood flow, invaluable for the determination of disease activity in those many patients affected by inflammatory bowel disease (IBD). IBD is a lifelong chronic disease and has its peak age of onset in adolescence or young adult life. Today, we have moved away from treating patient’s symptoms and strive instead to alter the course of disease by obtaining mucosal healing. Expensive and aggressive biologic therapies and lack of agreement of patient’s symptoms with their disease activity and complications necessitate frequent imaging surveillance, which must be safe, readily available, inexpensive, and effective. Ultrasound with the benefit of contrast enhancement meets these requirements and is shown in meta-analysis to be equivalent to CT and MRI scans for these indications. pubtype: Academic Journal doctype: Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|